ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment. Lele SJ, Adilbay D, Lewis E, Pang J, et al. Otolaryngol Head Neck Surg 2024 Apr 9. doi: 10.1002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lele SJ, Adilbay D, Lewis E, Pang J, et al. ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment. Otolaryngol Head Neck Surg 2024 Apr 9. doi: 10.1002.
PMID: 38591659